Wed, May 7, 6:37 PM (4 days ago)
**LivaNova PLC (LIVN) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** $316.9 million, up 7.4% YoY. - **Gross Profit:** $220.8 million, up 6.5% YoY. - **Operating Income:** $48.6 million, up 199.2% YoY. - **Net Loss:** $327.3 million, significantly higher due to SNIA environmental liability. - **Cash Flow from Operations:** $23.9 million, up 140.4% YoY. **Profit Margins:** - **Gross Margin:** 69.7%, down 0.6% YoY. - **Operating Margin:** 15.3%, up 11.8% YoY. **Cash Flow:** - **Operating Cash Flow:** $23.9 million, up 140.4% YoY. - **Investing Cash Flow:** -$10.6 million, down 67.6% YoY. - **Financing Cash Flow:** -$4.4 million, down 111.2% YoY. **Earnings Changes:** - **EPS:** -$6.01, down from -$0.78 YoY. **Quarterly Performance Discussion:** - **Cardiopulmonary Segment:** Revenue up 13.1% YoY, driven by Essenz Perfusion System sales and strong consumables demand. - **Neuromodulation Segment:** Revenue up 3.8% YoY, driven by strength in Europe and Rest of World regions. - **SNIA Environmental Liability:** Recorded a current liability of $360.4 million due to the Italian Supreme Court's decision. - **Cybersecurity Incident:** Incurred $12.4 million in direct costs, with additional costs expected. **Trends and Uncertainties:** - **Macroeconomic Environment:** FX volatility, inflation, geopolitical instability, and supply chain challenges impact operations. - **Legal and Regulatory:** Ongoing litigation and regulatory proceedings, including the SNIA environmental litigation and cybersecurity incident. - **Future Operations:** Continued focus on core segments, potential access to debt/equity markets for capital optimization. **Future Operations Impact:** - **Liquidity:** Sufficient to cover operating expenses, capital expenditures, and debt service requirements. - **Capital Expenditures:** $10.3 million, up 60.0% YoY, primarily for internal-use software. - **Debt Obligations:** $628.8 million, with $79.6 million current.